Vantage Consulting Group Inc

CIK 1843547 · View on SEC EDGAR ↗

Portfolio value
$19.7M
#8,908 of 9,443 by 13F value · top 94.3%
Positions
3
As of
Dec. 31, 2025 Data as of Q4 2025

Portfolio value QoQ: +75.8% 13F does not disclose cash

Top 10 holdings weight
100.00%
Top 25 holdings weight
100.00%
Positions above 1%
3
Effective number of positions
1.6

Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)

Turnover Q4 2025: 0.0% Est. buys $0 · sells $0

Median holding: 5.0 quarters Tracked Q4 2024–Q4 2025 · 60.0% still held

New positions
0
Increased
0
Decreased
0
Closed
1
On this page

Performance vs S&P 500

Tracked Q4 2024–Q4 2025
+169.3%
S&P 500 total return (same window)
+17.9%
Excess return
+151.5%

Annualized: +169.3% · S&P 500: +17.9%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 100.0% · Options excluded: 0.0%

Sector breakdown

Industrials
77.7%
Healthcare
22.3%

Full portfolio 3 positions

Type Streak 8Q trend
BW Babcock & Wilcox Enterprises, Inc. Common Stock $15,318,708 77.68% 2,416,200 $8,311,728
ADCT ADC Therapeutics SA Common Shares $2,410,983 12.23% 682,998 $-321,009
CBUS Cibus, Inc. - Class A Common Stock $1,990,471 10.09% 1,143,949 $514,777

Top movers (QoQ)

Security Action Shares Δ Value Δ
BW Price move only +0 +$8.3M
CBUS Price move only +0 +$515K
ADCT Price move only +0 -$321K

Exited positions

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

SecurityQuarter Shares before Value before Price since exit
PBPB March 31, 2025 164,875 $1,553,123 No longer tracked
FGEN June 30, 2025 195,707 $60,650 No longer tracked